NMR-based evaluation of the metabolic profile and response to dichloroacetate of human prostate cancer cells

NMR in Biomedicine

Volumn 27, Issue 5, 2014, Pages 610-616

  Kailavasan, Mithun ^a   Rehman, Ishtiaq ^a   Reynolds, Steven ^a   Bucur, Adriana ^a   Tozer, Gillian ^a   Paley, Martyn ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Bioreactor; Dichloroacetate; Lactate dehydrogenase; Metabolic biomarkers; NMR; Prostate cancer; Prostate specific antigen; Zymography

Indexed keywords

AMINO ACIDS; BIOMOLECULES; BIOREACTORS; CELL CULTURE; DISEASES; ENZYME INHIBITION; METABOLISM; METABOLITES; NUCLEAR MAGNETIC RESONANCE;

DICHLOROACETATE; LACTATE DEHYDROGENASE; METABOLIC BIOMARKERS; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; ZYMOGRAPHY;

CELLS;

ALANINE; CHOLINE; CREATINE; DICHLOROACETIC ACID; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE 1; LACTATE DEHYDROGENASE 2; LACTATE DEHYDROGENASE 3; LACTATE DEHYDROGENASE 5; LACTATE DEHYDROGENASE ISOENZYME 4; LACTIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BIOREACTOR; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; METABOLIC PARAMETERS; METASTASIS POTENTIAL; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROSTATE CANCER; TREATMENT RESPONSE; ZYMOGRAPHY; ANAEROBIC GROWTH; CELL SURVIVAL; DRUG EFFECTS; GLYCOLYSIS; METABOLISM; METABOLOME; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ANAEROBIOSIS; BIOREACTORS; CELL LINE, TUMOR; CELL SURVIVAL; DICHLOROACETIC ACID; GLYCOLYSIS; HUMANS; L-LACTATE DEHYDROGENASE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOME; PROSTATIC NEOPLASMS;

EID: 84897965532     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.3101     Document Type: Article

References (41)

1. Brawley OW. Trends in prostate cancer in the United States. J. Natl. Cancer Inst. Monogr. 2012; 45: 152-156.
2. Damber JE, Aus G. Prostate cancer. Lancet 2008; 371(9625): 1710-1721.
3. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin. Cancer Res. 2006; 12(20 Pt 2): 6243s-6249s.
4. LaSpina M, Haas GP. Update on the diagnosis and management of prostate cancer. Can. J. Urol. 2008; 15(Suppl 1): 3-13; discussion 13.
5. Lilja H, Ulmert D, Vickers AJ. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat. Rev. Cancer 2008; 8(4): 268-278.
6. Evans CA, Glen A, Eaton CL, Larré S, Catto JWF, Hamdy FC, Wright PC, Rehman I. Prostate cancer proteomics: the urgent need for clinically validated biomarkers. PROTEOMICS - Clin. Appl. 2009; 3(2): 197-212.
7. Killick E, Bancroft E, Kote-Jarai Z, Eeles R. Beyond prostate-specific antigen - future biomarkers for the early detection and management of prostate cancer. Clin. Oncol. (R. Coll. Radiol.) 2012; 24: 545-555.
8. Cooper G. The Cell: A Molecular Approach. The Mechanism of Oxidative Phosphorylation. Sinauer Associates: Sunderland, MA; 2000.
9. Markert CL. Lactate dehydrogenase isozymes: dissociation and recombination of subunits. Science 1963; 140(3573): 1329-1330.
10. Seth P, Grant A, Tang J, Vinogradov E, Wang X, Lenkinski R, Sukhatme VP. On-target inhibition of tumor fermentative glycolysis as visualized by hyperpolarized pyruvate. Neoplasia 2011; 13(1): 60-71.
11. Warburg O. On Metabolism of Tumors. Constable: London; 1930.
12. Dakubo G. Mitochondrial Genetics and Cancer, 1st edn. Springer: Thunder Bay, Canada; 2010.
13. Dang CV, Le A, Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin. Cancer Res. 2009; 15(21): 6479-6483.
14. Rajagopalan KN, DeBerardinis RJ. Role of glutamine in cancer: therapeutic and imaging implications. J. Nucl. Med. 2011; 52(7): 1005-1008.
15. Moore S, Knudsen B, True LD, Hawley S, Etzioni R, Wade C, Gifford D, Coleman I, Nelson PS. Loss of stearoyl-CoA desaturase expression is a frequent event in prostate carcinoma. Int. J. Cancer 2005; 114(4): 563-571.
16. Ntambi JM. Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J. Lipid Res. 1999; 40(9): 1549-1558.
17. Doherty JR, Cleveland JL. Targeting lactate metabolism for cancer therapeutics. J. Clin. Invest. 2013; 123(9): 3685-3692.
18. Marisha Ben-Tchavtchavadze MP, Jolicoeur M. Small-scale bioreactor platform for bioprocess optimization. Pharm. Eng. 2007; 27(5): 1-10.
19. Keshari KR, Kurhanewicz J, Jeffries RE, Wilson DM, Dewar BJ, Van Criekinge M, Zierhut M, Vigneron DB, Macdonald JM. Hyperpolarized (13)C spectroscopy and an NMR-compatible bioreactor system for the investigation of real-time cellular metabolism. Magn. Reson. Med. 2010; 63(2): 322-329.
20. Van der Graaf RS, Oosterhof GO, Schalken JA, Verhofstad AA, Heerschap A. Proton MR spectroscopy of prostatic tissue focused on the detection of spermine, a possible biomarker of malignant behavior in prostate cancer. MAGMA 2000; 10: 153-159.
21. 31P NMR spectroscopy. J. Biol. Chem. 1987; 262(31): 14 875-14 878.
22. O'Donnell JM, Kudej RK, LaNoue KF, Vatner SF, Lewandowski ED. Limited transfer of cytosolic NADH into mitochondria at high cardiac workload. Am. J. Physiol. Heart Circ. Physiol. 2004; 286(6): H2237-H2242.
23. Williamson DH, Lund P, Krebs HA. The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem. J. 1967; 103(2): 514-527.
24. Sugden MH. Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs. Am. J. Physiol. Endocrinol. Metab. 2003; 284: E855-E862.
25. Michelakis ED, Sutendra G, Dromparis P, Webster L, Haromy A, Niven E, Maguire C, Gammer TL, Mackey JR, Fulton D, Abdulkarim B, McMurtry MS, Petruk KC. Metabolic modulation of glioblastoma with dichloroacetate. Sci. Transl. Med. 2010; 2: 31-34.
26. + channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 2007; 11(1): 37-51.
27. Cao WYS, Shiverick KT, Namiki K, Sakai Y, Porvasnik S, Urbanek C, Rosser CJ. Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation. Prostate 2008; 68: 1223-1231.
28. Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ, Fidler IJ. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin. Cancer Res. 1996; 2(9): 1627-1636.
29. Leiblich A, Cross SS, Catto JW, Phillips JT, Leung HY, Hamdy FC, Rehman I. Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer. Oncogene 2006; 25(20): 2953-2960.
30. Brown NJ, Higham SE, Perunovic B, Arafa M, Balasubramanian S, Rehman I. Lactate dehydrogenase-B is silenced by promoter methylation in a high frequency of human breast cancers. PLoS One 2013; 8(2): e57697.
31. Marisha Ben-Tchavtchavadze JC, Perrier M, Jolicoeur M. A noninvasive technique for the measurement of the energetic state of free-suspension mammalian cells. Biotechnol. Prog. 2010; 26(2): 532-541.
32. Gmati D, Chen J, Jolicoeur M. Development of a small-scale bioreactor: application to in vivo NMR measurement. Biotechnol. Bioeng. 2005; 89(2): 138-147.
33. Maekawa M, Taniguchi T, Ishikawa J, Sugimura H, Sugano K, Kanno T. Promoter hypermethylation in cancer silences LDHB, eliminating lactate dehydrogenase isoenzymes 1-4. Clin. Chem. 2003; 49(9): 1518-1520.
34. Koukourakis MI, Giatromanolaki A, Sivridis E. Lactate dehydrogenase isoenzymes 1 and 5: differential expression by neoplastic and stromal cells in non-small cell lung cancer and other epithelial malignant tumors. Tumour Biol. 2003; 24(4): 199-202.
35. Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, Royer RE, Vander Jagt DL, Semenza GL, Dang CV. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc. Natl. Acad. Sci. U. S. A. 2010; 107(5): 2037-2042.
36. 2 on hypoxic HeLa cells. Anticancer Res 2009; 29(11): 4579-4588.
37. Madhok BM, Yeluri S, Perry SL, Hughes TA, Jayne DG. Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells. Br. J. Cancer 2010; 102(12): 1746-1752.
38. Rofstad EK, Mathiesen B, Kindem K, Galappathi K. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res. 2006; 66(13): 6699-6707.
39. Schwickert G, Walenta S, Sundfor K, Rofstad EK, Mueller-Klieser W. Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res. 1995; 55(21): 4757-4759.
40. Jones NP, Schulze A. Targeting cancer metabolism-aiming at a tumour's sweet-spot. Drug Discov. Today 2012; 17(5-6): 232-241.
41. Bailey KM, Wojtkowiak JW, Hashim AI, Gillies RJ. Targeting the metabolic microenvironment of tumors. Adv. Pharmacol. 2012; 65: 63-107.